Extraribosomal l13a is a specific innate immune factor for antiviral defense.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 4136244)

Published in J Virol on June 04, 2014

Authors

Barsanjit Mazumder1, Darshana Poddar2, Abhijit Basu2, Ravinder Kour2, Valentina Verbovetskaya2, Sailen Barik1

Author Affiliations

1: Center for Gene Regulation in Health and Disease, Department of Biological, Geological and Environmental Sciences, Cleveland State University, Cleveland, Ohio, USA b.mazumder@csuohio.edu s.barik@csuohio.edu.
2: Center for Gene Regulation in Health and Disease, Department of Biological, Geological and Environmental Sciences, Cleveland State University, Cleveland, Ohio, USA.

Articles cited by this

Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res (2003) 77.89

The complete atomic structure of the large ribosomal subunit at 2.4 A resolution. Science (2000) 28.25

RNA virus mutations and fitness for survival. Annu Rev Microbiol (1997) 10.06

Genome-wide analysis of mRNA translation profiles in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (2003) 7.45

Pathogen recognition by the innate immune system. Int Rev Immunol (2011) 5.76

Identification of eukaryotic mRNAs that are translated at reduced cap binding complex eIF4F concentrations using a cDNA microarray. Proc Natl Acad Sci U S A (1999) 4.12

Quantitative analysis of Argonaute protein reveals microRNA-dependent localization to stress granules. Proc Natl Acad Sci U S A (2006) 4.02

Translational control by the 3'-UTR: the ends specify the means. Trends Biochem Sci (2003) 4.00

Inhibition of respiratory viruses by nasally administered siRNA. Nat Med (2004) 3.69

Crystal structure of the eukaryotic ribosome. Science (2010) 3.57

Noncanonical function of glutamyl-prolyl-tRNA synthetase: gene-specific silencing of translation. Cell (2004) 3.12

Regulated release of L13a from the 60S ribosomal subunit as a mechanism of transcript-specific translational control. Cell (2003) 3.07

Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res (2011) 2.51

Biological challenges and technological opportunities for respiratory syncytial virus vaccine development. Immunol Rev (2011) 2.04

Accessory molecules for Toll-like receptors and their function. Nat Rev Immunol (2012) 2.00

Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses. BMC Microbiol (2001) 1.89

LINE-1 ORF1 protein localizes in stress granules with other RNA-binding proteins, including components of RNA interference RNA-induced silencing complex. Mol Cell Biol (2007) 1.79

DAPK-ZIPK-L13a axis constitutes a negative-feedback module regulating inflammatory gene expression. Mol Cell (2008) 1.70

Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections. J Virol (2005) 1.68

Cloning and expression of the vesicular stomatitis virus phosphoprotein gene in Escherichia coli: analysis of phosphorylation status versus transcriptional activity. J Virol (1991) 1.60

Exponential fitness gains of RNA virus populations are limited by bottleneck effects. J Virol (1999) 1.60

Transcript-selective translational silencing by gamma interferon is directed by a novel structural element in the ceruloplasmin mRNA 3' untranslated region. Mol Cell Biol (2003) 1.53

Respiratory syncytial virus induces host RNA stress granules to facilitate viral replication. J Virol (2010) 1.51

Regulation of stress granules in virus systems. Trends Microbiol (2012) 1.46

Nonstructural proteins of respiratory syncytial virus suppress premature apoptosis by an NF-kappaB-dependent, interferon-independent mechanism and facilitate virus growth. J Virol (2006) 1.46

Risk factors for severe respiratory syncytial virus lower respiratory tract infection. Open Microbiol J (2011) 1.45

Respiratory syncytial virus nonstructural proteins decrease levels of multiple members of the cellular interferon pathways. J Virol (2009) 1.34

Genome-wide polysome profiling reveals an inflammation-responsive posttranscriptional operon in gamma interferon-activated monocytes. Mol Cell Biol (2008) 1.29

Human ribosomal protein L13a is dispensable for canonical ribosome function but indispensable for efficient rRNA methylation. RNA (2007) 1.23

Mapping the transcription and replication promoters of respiratory syncytial virus. J Virol (2002) 1.20

Delayed translational silencing of ceruloplasmin transcript in gamma interferon-activated U937 monocytic cells: role of the 3' untranslated region. Mol Cell Biol (1999) 1.17

Productive infection of isolated human alveolar macrophages by respiratory syncytial virus. J Clin Invest (1990) 1.13

Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS. J Virol (2012) 1.13

Complete sequence of the RNA genome of pneumonia virus of mice (PVM). Virus Genes (2005) 1.10

Relationship of GW/P-bodies with stress granules. Adv Exp Med Biol (2013) 1.07

Roles of the respiratory syncytial virus trailer region: effects of mutations on genome production and stress granule formation. Virology (2010) 1.06

Respiratory syncytial virus mechanisms to interfere with type 1 interferons. Curr Top Microbiol Immunol (2013) 0.97

The discovery and analysis of P Bodies. Adv Exp Med Biol (2013) 0.91

An extraribosomal function of ribosomal protein L13a in macrophages resolves inflammation. J Immunol (2013) 0.88

Respiratory syncytial virus interaction with human airway epithelium. Trends Microbiol (2013) 0.88

Function of GW182 and GW bodies in siRNA and miRNA pathways. Adv Exp Med Biol (2013) 0.87

p38 and OGT sequestration into viral inclusion bodies in cells infected with human respiratory syncytial virus suppresses MK2 activities and stress granule assembly. J Virol (2012) 0.87

RNAi-dependent and -independent antiviral phenotypes of chromosomally integrated shRNA clones: role of VASP in respiratory syncytial virus growth. J Mol Med (Berl) (2007) 0.81

Evaluation of pneumonia virus of mice as a possible human pathogen. J Virol (2012) 0.80

Insights into the mechanism of ribosomal incorporation of mammalian L13a protein during ribosome biogenesis. Mol Cell Biol (2013) 0.80

Pattern recognition receptors in infectious skin diseases. Microbes Infect (2012) 0.78

The impact of Toll-like receptors on bacterial virulence strategies. Curr Opin Microbiol (2013) 0.77